NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Wearable Medical Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 347347
出版日期 內容資訊 英文 130 Pages
商品交期: 2-3個工作天內
全球穿戴式醫療設備市場:成長、預測、趨勢 Wearable Medical Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
出版日期: 2021年03月01日內容資訊: 英文 130 Pages







  • 目前市場情況
  • 波特的五力分析


  • 市場成長的促進要素
  • 市場成長的阻礙因素
  • 市場機會
  • 主要課題


  • 各產品類型
    • 穿戴式生理監護器
    • 穿戴式胎兒分娩監視器
    • 神經監測設備
    • 穿戴式疼痛管理設備
    • 血糖值、胰島素監測設備
    • 穿戴式呼吸療法設備
  • 各用途
    • 運動、健身設備
    • 遠端患者監護
    • 居家醫療
  • 各設備類型
    • 手錶
    • 腕帶
    • 服裝類
    • 耳部
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美


  • M&A分析
  • 協定,合作及合作
  • 新產品銷售


  • Actelion Pharmaceuticals
  • Apple
  • Fitbit
  • Lifesense
  • LifeWatch AG
  • Philips Electronics
  • Samsung
  • Sotera Wireless
  • Xiaomi Inc.
  • 其他



Product Code: 47294

The wearable medical devices market was valued at USD 19,450 million in 2020 and is expected to reach USD 47,837 million by 2026, registering a CAGR of about 16% over the forecast period.

Wearable devices play a crucial role in predicting certain disorders by integrating essential vital signs with clinical symptomology. The use of wearable devices in a bid to combat COVID-19 has therefore been ramped up. Research has recently expanded on which if the extensive data that wearable devices collect can predict the onset of the virus or not.

For instance, in 2020, researchers at Rockefeller Neuroscience Institute in the United States reported that data from the Oura ring, a wearable sleep and activity tracker, can be combined with an app that measures vital signs that predict in advance if an individual is likely to develop COVID-19 symptoms. The device successfully predicted that an individual would experience symptoms such as shortness of breath, cough, fever up to three days before they manifested.

The wearable medical devices market is growing at a faster pace owing to the rising technological innovations and advancements, as they can improve the lifestyle of general population as well as patients population. Wearable technologies proffer a convenient mode of monitoring physiological symptoms, featuring a multitude of medical solutions. These are devices are not only easy for the consumer use, but they also offer real-time data for physicians to analyze as well. From the Apple Watch's EKG capabilities to new continuously glucose monitoring systems, wearable medical technologies have a broad range of potential applications in healthcare industry.

Also, Current Health's artificial intelligence (AI) wearable device that measures multiple vital signs has recently received FDA-clearance for patients to use at home. In February 2020, the Edinburgh, Scotland-based company received clearance for the AI-enabled device in monitoring patients while in the hospital, but this recent approval means it can now be used between doctor visits at home too.

In 2019, Omron Healthcare launched HealthGuide, which looks like a typical smartwatch but is incorporated with feature to monitor blood pressure. Thus, all the above mentioned factors are responsible for the growth of the market.

However, the lack of awareness about the availability of some wearable devices in developing and underdeveloped countries and the high cost of wearable devices are some of the major challenges for the growth prospects of the market.

Key Market Trends

Remote Patient Monitoring is Expected to Exhibit Fastest Growth Rate Over Forecast Period

The essential and healthcare workers are the most vulnerable to coronavirus infections due to their required proximity to potential coronavirus patients. Wearable technology may potentially help in these regards by providing symptoms prediction, real-time remote monitoring and contact tracing, etc.

In April 2020, the Scripps Research Translational Institute has started the DETECT (Digital Engagement & Tracking for Early Control & Treatment) Study, which uses devices such as Garmin, Fitbit, Apple Watch among others for recording activity, heart rate, and sleep data and matching it with symptom reports submitted by participants to track potential cases of COVID-19. Early results from the study showed that Fitbits can predict COVID-19 in 78% of the 14 patients studied.

The process in which patients can use a mobile medical device to perform a routine test and send this data to healthcare professionals in real-time is known as Remote patient monitoring (RPM).

The implementation of remote patient monitoring may improve the management of chronic disorders by measuring critical risk indicators, such as blood pressure and glucose. RPM has several advantages for hospitals and end users, such as reduction in extended hospitalization, low cost of healthcare and fewer doctor appointments. This can also help to lower the cost associated with the treatment of chronic disorders.

The increase in the number of people with chronic disorders and an rising elderly population are the major factors boosting the growth of RPM services across the globe. For instance, the number of deaths of neurological disorders has increased in the past three decades, i.e., from 6.5 million in 1990 to 9 million in 2018, as per Feigin V.L. published in the Neuroepidemiology Journal 2019. This rising prevalence is anticipated to further increase the demand for remote patient monitoring devices.

North America Captured the Largest Market Share and It is Expected to Retain its Dominance over the Forecast Period

The COVID-19 has altered collective and individual behavior, changing both workplace and healthcare. Technology offers devices to meet these new challenges. When it comes to health, work, and economics amid COVID-19, wearables play an important role in the entire continuum of care, as well as in our work and leisure lives. In 2020, Philips launched a next-generation wearable biosensor for early patient deterioration detection, including clinical surveillance for COVID-19 in the United States.

Also, in 2020, researchers in Washington have developed a stamp-sized device, consisting of a suite of sensors, including ones that record blood oxygen levels and body temperature, an advance that can be used to catch early symptoms and signs of COVID-19 and help to monitor patients as the illness progresses.

North America dominated the overall wearable medical devices market, with the United States emerging as the major contributor to the market. The United States holds the largest share in the wearable medical devices market, due to the high prevalence of cardiovascular and lifestyle-related diseases and an increased adoption of wearable medical technology along with high per capita medical expenditure. Combined with the rising incidence of diseases in the region, the market for wearable medical devices is expected to grow at a moderate rate, over the forecast period.

Additionally, most of the major players such as Garmin Ltd, Fitbit, Inc and Biotelemetry, Inc of the studied market are concentrated in United States and has been investing in the research and development of innovative wearables. For instance, in Oct 2020, Garmin Ltd has launched Vivofit jr, 3 kids fitness tracker watch, which would help kids to be motivated to meet their activity goals in order to see what happens next in the app adventure.

Competitive Landscape

The rising number of market players is intensifying the competition. Players, such as Fitbit, Lifesense, Apple, Garmin, and Samsung, are disrupting the market by launching several new products. In Aug 2020, Fitbit, Inc launched Fitbit Sense, advanced health smart watch that helps in detecting the body's responses to stressors by measuring electrodermal activity responses.

Moreover, new competitors are emerging in the form of start-ups. Start-ups like Overlap, Royal Philips, Vivify Health, Validic, and Doximity Dialer are in the process of developing technology to enhance wearable health technology and enable EHR integration for health systems. This has made the market very competitive.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Technological Advancements and Innovations
    • 4.2.2 Increasing Per-capita Income in Developing Countries
    • 4.2.3 Ease-of-use and Interpretation of Medical Devices
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Wearable Devices
    • 4.3.2 Unfavorable Reimbursement Issues
    • 4.3.3 Current Lack of Awareness in Some Regions
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Device Type
    • 5.1.1 Diagnostic Devices
      • Vital Sign Monitoring Devices
      • Sleep Monitoring Devices
      • Electrocardiographs Fetal And Obstetric Devices
      • Neuromonitoring Devices
    • 5.1.2 Therapeutic Devices
      • Pain Management Devices
      • Rehabilitation Devices
      • Respiratory Therapy Devices
      • Other Therapeutic Devices
  • 5.2 By Application
    • 5.2.1 Sports and Fitness
    • 5.2.2 Remote Patient Monitoring
    • 5.2.3 Home Healthcare
  • 5.3 By Product Type
    • 5.3.1 Watch
    • 5.3.2 Wristband
    • 5.3.3 Ear Wear
    • 5.3.4 Other Product Types
  • 5.4 By Geography
    • 5.4.1 North America
      • United States (By Device Type, By Application and By Product)
      • Canada (By Device Type, By Application and By Product)
      • Mexico (By Device Type, By Application and By Product)
    • 5.4.2 Europe
      • United Kingdom (By Device Type, By Application and By Product)
      • Germany (By Device Type, By Application and By Product)
      • France (By Device Type, By Application and By Product)
      • Italy (By Device Type, By Application and By Product)
      • Spain (By Device Type, By Application and By Product)
      • Rest of Europe
    • 5.4.3 Asia-Pacific
      • China (By Device Type, By Application and By Product)
      • Japan (By Device Type, By Application and By Product)
      • India (By Device Type, By Application and By Product)
      • Australia (By Device Type, By Application and By Product)
      • South Korea (By Device Type, By Application and By Product)
      • Rest of Asia-Pacific (By Device Type, By Application and By Product)
    • 5.4.4 Middle East and Africa
      • GCC (By Device Type, By Application and By Product)
      • South Africa (By Device Type, By Application and By Product)
      • Rest of Middle East and Africa (By Device Type, By Application and By Product)
    • 5.4.5 South America
      • Brazil (By Device Type, By Application and By Product)
      • Argentina (By Device Type, By Application and By Product)
      • Rest of South America (By Device Type, By Application and By Product)


  • 6.1 Company Profiles
    • 6.1.1 Proteus Digital Health
    • 6.1.2 Apple Inc.
    • 6.1.3 Basis Science, Inc.
    • 6.1.4 Everist Genomics
    • 6.1.5 Fitbit
    • 6.1.6 Garmin Ltd
    • 6.1.7 imec
    • 6.1.8 Intelesens Ltd.
    • 6.1.9 Jawbone
    • 6.1.10 Lifesense
    • 6.1.11 LifeWatch AG
    • 6.1.12 Medtronic PLC
    • 6.1.13 Pebble Technology Corp
    • 6.1.14 Philips Electronics
    • 6.1.15 Polar Electro
    • 6.1.16 Samsung
    • 6.1.17 Sotera Wireless
    • 6.1.18 Xiaomi Inc.